Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,686,936.21
- $26,153,928.11
- June 18, 2025
- Todd Franklin Watanabe
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 6, 2021 | CEO | 1,750 | $26.58 | Sell | $46,515.00 | |
| July 1, 2021 | Director | 2,200 | $26.13 | Sell | $57,486.00 | |
| June 24, 2021 | Director | 729 | $27.50 | Sell | $20,047.50 | |
| June 21, 2021 | Director | 2,516 | $27.50 | Sell | $69,190.00 | |
| June 7, 2021 | CEO | 1,750 | $26.35 | Sell | $46,112.50 | |
| May 7, 2021 | CEO | 750 | $35.00 | Sell | $26,250.00 | |
| May 5, 2021 | CEO | 1,750 | $34.00 | Sell | $59,500.00 | |
| April 20, 2021 | Director | 10,000 | $28.06 | Sell | $280,600.00 | |
| April 5, 2021 | CEO | 1,750 | $29.93 | Sell | $52,377.50 | |
| April 1, 2021 | Director | 2,200 | $29.49 | Sell | $64,878.00 | |
| March 22, 2021 | Director | 10,000 | $31.10 | Sell | $311,000.00 | |
| March 5, 2021 | CEO | 1,750 | $30.55 | Sell | $53,462.50 | |
| Feb. 10, 2021 | CFO | 750 | $35.64 | Sell | $26,730.00 | |
| Feb. 1, 2021 | Director | 9,949 | $33.25 | Sell | $330,804.25 | |
| Feb. 1, 2021 | CFO | 1,250 | $35.00 | Sell | $43,750.00 | |
| Jan. 29, 2021 | Director | 51 | $27.50 | Sell | $1,402.50 | |
| Jan. 19, 2021 | CFO | 500 | $30.00 | Sell | $15,000.00 | |
| Dec. 1, 2020 | Director | 2,200 | $25.98 | Sell | $57,156.00 | |
| Oct. 1, 2020 | Director | 2,200 | $27.65 | Sell | $60,830.00 | |
| Sept. 29, 2020 | Insider | 15,000 | $30.00 | Sell | $450,000.00 | |
| Sept. 29, 2020 | CFO | 500 | $30.00 | Sell | $15,000.00 | |
| Sept. 29, 2020 | CEO | 3,000 | $30.00 | Sell | $90,000.00 | |
| Sept. 1, 2020 | Director | 2,200 | $24.38 | Sell | $53,636.00 | |
| Aug. 3, 2020 | Director | 2,800 | $25.63 | Sell | $71,764.00 | |
| Feb. 4, 2020 | Major Shareholder | 500,000 | $24.10 | Buy | $12,050,000.00 | |
| Feb. 3, 2020 | Director | 558,888 | $25.64 | Buy | $14,329,888.32 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Larry Todd Edwards, Patricia A Turney, Patrick J Heron, Orbimed Advisors Llc, Life Sciences Viii L Frazier, Watanabe Todd Franklin, David W Osborne, David W. Osborne, Welgus Howard G., Terrie Curran, Jonathan Silverstein, David Joseph Topper, Howard G. Welgus, and OSBORNE DAVID W
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 31 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on June 18, 2025.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.